News

MGI Tech Strengthens Global Position with Exclusive Deal

MGI Tech Strengthens Global Position with Exclusive Deal

MGI Tech Enters Strategic Agreement with Swiss Rockets AG

In a significant move to expand its global reach, MGI Tech Co., Ltd. has announced an exclusive licensing agreement with Swiss Rockets AG. This partnership aims to harness MGI's innovative CoolMPSä sequencing technology, which is designed to reshape the landscape of genomic research and biotechnology.

Understanding CoolMPS Technology

CoolMPS technology stands out in the field of sequencing innovations due to its unique antibody-based recognition chemistry. This advanced technology resolves the issue of DNA "scarring" typically associated with conventional long-read sequencing methods. By employing natural nucleotides and innovative extension blocks along with labeled antibodies, CoolMPS provides exceptionally reliable genomic data.

Benefits of the CoolMPS Approach

By integrating labeled multiple fluorescent dye antibodies with nucleotides, CoolMPS offers an impressive sequencing capability, delivering reads of up to 600 to 700 bases. This high fidelity is particularly crucial for applications such as early cancer detection and comprehensive genomic analysis, allowing researchers to gather longer and more accurate reads at a reduced cost.

Exclusive Licensing Rights

Within the framework of the licensing agreement, Swiss Rockets AG receives exclusive rights to MGI's intellectual property related to CoolMPS technology. This encompasses not only patents but also essential know-how and software, enabling Swiss Rockets to develop and manufacture relevant products for markets outside certain regions.

Expansion Plans by Swiss Rockets AG

Backed by a notable investment partnership with Emergent BioSolutions, Swiss Rockets AG is poised to utilize this licensing deal to enhance CoolMPS's global applications. The company plans to manufacture CoolMPS sequencers and consumables, thereby solidifying its presence in critical markets such as the US and Europe.

Alignment with Healthcare Goals

The adoption of CoolMPS technology extends beyond mere sequencing; it aligns with the mission of Swiss Rockets AG to innovate in oncology and viral disease therapies. This synergy aims to enhance personalized medicine, focusing on effective treatments tailored to individual patient needs.

Impacts on Global Health

This collaboration represents a pivotal development for MGI as it seeks to maximize the global impact of CoolMPS technology. The partnership aims to not just scale operations but also deliver innovative solutions that enhance overall public health.

Leadership Perspectives

Dr. Rade Drmanac, MGI's Chief Scientific Officer, expressed enthusiasm about the partnership, stating it reinforces MGI's commitment to technological leadership in genomic sequencing. Similarly, Dr. Vladimir Cmiljanovic, CEO of Swiss Rockets AG, highlighted the potential of CoolMPS to transform oncology and disease treatment frameworks.

About MGI Tech

MGI Tech Co., Ltd. is at the forefront of developing cutting-edge tools and technologies that propel advancements in life sciences. With a focus on research and manufacturing, MGI delivers precision equipment and systems that cater to precision medicine, agriculture, and healthcare sectors.

About Swiss Rockets AG

Swiss Rockets AG acts as both an incubator and accelerator for biotechnology and precision healthcare start-ups, particularly in oncology. The organization is committed to developing impactful therapies and solutions for healthcare challenges.

Frequently Asked Questions

What is the CoolMPS technology?

CoolMPS technology is an innovative sequencing method that utilizes antibody-based recognition chemistry to eliminate DNA scarring and enhance the accuracy of genomic data.

What is the purpose of the licensing agreement?

The licensing agreement allows Swiss Rockets AG exclusive rights to utilize MGI's CoolMPS technology for research, development, and commercialization outside specific regions.

How will this partnership impact health solutions?

The partnership aims to significantly enhance global health solutions by leveraging CoolMPS for early disease detection and advanced personalized medicine.

What markets will Swiss Rockets target with CoolMPS?

Swiss Rockets plans to target markets primarily in the US and Europe by manufacturing sequencers and consumables related to CoolMPS technology.

What potential does this deal hold for future innovations?

This partnership is expected to drive further innovations in genomics and personalized medicine, paving the way for improved health outcomes globally.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Updated Category News Views 22

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Continue Reading
TIGR Investors Eye Class Action Amid Legal Woes

Updated Category News Views 36

A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...

Continue Reading
Coastal Financial Faces $470M Wipeout: Investor Alert

Updated Category News Views 82

Revelations Hit Coastal Financial Hard Alright, pull up a chair and let’s chew over what just happened with Coastal Financial Corporation (NASDAQ: CCB). This is the sort of deal that makes seasoned investors shake their heads in disbelief. Between October 28, 2024, and July 29, 2026, anyone buying into Coastal was buying into a mess they didn’t sign up for. We're...

Continue Reading
Brookdale Ready to Share Insights at Stephens Conference

Updated Category News Views 59

Navigating Through the Senior Living Space Oh, the world of senior living—never a dull moment and full of its own nuances. Brookdale Senior Living Inc., right in the thick of it, is prepping to lay it all out at the Stephens Annual Investment Conference this year. Now, they're taking the stage in Nashville on November 19, brimmed with numbers, charts, and possibly a...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 17

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Chicken Salad Chick Expands in PA with Collegeville Launch

Updated Category News Views 113

Chicken Salad Chick Expands Further into Pennsylvania Hot off the grill! If you're in Pennsylvania, especially around Collegeville, you might want to perk up. Chicken Salad Chick, that quirky Southern-style restaurant chain that's all about—you guessed it—chicken salad, is doubling down on its presence in the state. Come November 18, chicken enthusiasts can graze on...

Continue Reading
Aethlon's Merger Moves: High Stakes and High Hopes

Updated Category News Views 59

Two-Step Merger Raises Eyebrows It's not every day you see a company like Aethlon Medical, Inc. (NASDAQ: AEMD) shake up its core operations with a bold merger move. On September 17, 2026, Aethlon signed off on a Plan of Merger and Reorganization with North Immunology, Inc.—a clear signal to investors that the winds of change are blowing strong. Implications of the...

Continue Reading
LITEON Unveils Edge AI and Power Solutions at Electronica

Updated Category News Views 18

Redefining AI Infrastructure with LITEON Strolling through the electronica 2026 event in Munich, you can't help but notice LITEON flexing its muscles in the AI space. No fluffy marketing talk here—it's all about hard-core tech stats and future-proofing AI infrastructure. They're touting AI innovations that scale from cloud juggernauts to nimble edge applications, which...

Continue Reading
Fiduciary Breach Inquiry: The Stakes for Driven Brands

Updated Category News Views 94

What’s Going Down at Driven Brands? The legal eagles at Halper Sadeh LLC are sniffing around Driven Brands Holdings Inc. (NASDAQ:DRVN) to see if management's been playing fast and loose with fiduciary duties. Now, for you greenhorns out there, this ain't just your garden-variety legal activity. It’s a full-blown investigation to determine whether some corporate...

Continue Reading
Bongiorno Probes Deadly Brooklyn Building Collapse

Updated Category News Views 78

A Grim Scene Unfolds in Flatbush, Brooklyn Some days start with headlines you'd rather not see, and November 11, 2026, painted a picture straight out of a nightmare. A building went belly-up in the heart of Brooklyn's Flatbush neighborhood, leaving a tragic tally in its wake—8 dead, including two kids, and 18 others carrying the burden of injuries. We're staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

Trade Nation Merges TD365 Brand to Enhance User Experience

Updated Category News Views 202

Trade Nation Merges TD365 Brand for Seamless Experience Trade Nation, an award-winning fintech and financial services provider, is integrating its TD365 trading platform under the Trade Nation brand. This move aims to enhance the customer experience by offering a unified platform where users will log in through the Trade Nation interface. This transition will eliminate...

Continue Reading
Transforming Polish Rail: Alstom's Deal for Coradia Max Trains

Updated Category News Views 149

Alstom Partners with PKP Intercity for a Major Train Project In a significant move for the future of rail travel in Poland, Alstom, a leader in smart mobility solutions, has secured a deal with PKP Intercity, the national operator for long-distance trains. This collaboration will see the production of 42 Coradia Max trains, along with a substantial 30-year maintenance...

Continue Reading
Understanding the Impact of Tariffs on Global Trade Dynamics

Updated Category News Views 373

Introduction to Tariffs and their Global Implications Tariffs, as one of the most potent tools in trade policy, hold significant influence over international economic relations. Recently, the U.S. has prepared to introduce 25% tariffs on imports from major trading partners, stirring a wave of concern not only in Canada and Mexico but also impacting China and the broader...

Continue Reading
Balancing Work and Study: James Kindelsperger’s Journey

Updated Category News Views 179

Pursuing a Rutgers MBA While Managing Work and Family James Kindelsperger embarked on a remarkable journey while enrolled in the Rutgers Part-Time MBA program. This program provided him with the skills he needed to thrive academically and professionally. During his studies, Kindelsperger successfully landed a new job that not only expanded his responsibilities but also...

Continue Reading
Portugal's Stock Market Struggles with Sector Declines

Updated Category News Views 188

Portugal's Stock Market Overview Recently, the stock market in Portugal experienced a notable decline as sectors including Industrials, Consumer Services, and Technology saw losses, impacting investor sentiment. This downturn led to a closing drop of 0.73% in the PSI index, marking a continuation of troubling trends for investors. Key Contributors to the Market Decline...

Continue Reading